Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model

Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating disease of the central nervous system (CNS). There is no known cure for MS, and currently available drugs for managing this disease are only effective early on and have many adverse side effects. Results from recent studies suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Telles, Elphine, Karl, Molly, Cheng, Fengdong, Luetteke, Noreen, Sotomayor, Eduardo M, Miller, Robert H, Seto, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238389/
https://www.ncbi.nlm.nih.gov/pubmed/30456376
http://dx.doi.org/10.26508/lsa.201800039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238389/
https://www.ncbi.nlm.nih.gov/pubmed/30456376
http://dx.doi.org/10.26508/lsa.201800039

Ejemplares similares